Gateway 2011: GE Analytical Instruments
Your online Gateway to GE Analytical Instruments in 2011
6060 Spine Road
Boulder, CO 80301
303-444-2009/ 800 255-6964
www.geinstruments.com
About GE Analytical Instruments
InnovOx Lab & On-Line Wastewater TOC Analyzers
GE Analytical Instruments, a division of GE Water & Process Technologies, is dedicated to providing state-of-the-art instruments for simpler, faster, and more accurate analytical measurement of contaminants in water. The global leader in instruments used to measure total organic carbon (TOC) in water, GE Analytical Instruments is known for its technical innovations and holds over 30 patents. GE Analytical Instruments is ISO 9001-2008 registered. Sievers is the leading global TOC analyzer brand for pharmaceutical applications, with thousands of installations worldwide. Sievers TOC laboratory, on-line and portable analyzers are known for their unsurpassed analytical performance and ease of use.
Sievers Family Ultrapure Water TOC Analyzers
For more information:
geai@ge.com
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
